JOR Spine 8 , e70045 (2025)
Its a conversation that should be held between each patient and their practitioner to weigh the risks of continuing with the medication versus the risks of stopping, Dr
Hohenfellner K, Rauch F, Ariceta G, Awan A, Bacchetta J, Bergmann C, Bechtold S, Cassidy N, Deschenes G, Elenberg E, Gahl WA, Greil O, Harms E, Herzig N, Hoppe B, Koeppl C, Lewis MA, Levtchenko E, Nesterova G, Santos F, Schlingmann KP, Servais A, Soliman NA, Steidle G, Sweeney C, Treikauskas U, Topaloglu R, Tsygin A, Veys K, R VV, Zustin J, Haffner D (2019) Management of bone disease in cystinosis: statement from an international conference
Clinical studies in HBV-positive patients with alcohol use show distinct immune alterations depending on disease stage
The most effective therapy available now is Zepbound, which causes about 20% weight loss